Ron Wooten

From Wikipedia, the free encyclopedia

Ronald John Wooten (born June 29, 1959 in Bourne, Massachusetts) was a guard who played seven professional seasons with the New England Patriots in the National Football League.
Wooten attended the University of North Carolina. Wooten is now the president of NovaQuest and the executive vice president of corporate development at Quintiles Transnational Corporation.

Ron Wooten
Date of birth:	June 29, 1959 (1959-06-29) (age 48)
Place of birth:	Bourne, MA
Career information
Position(s):	Guard
College:	North Carolina
NFL Draft:	1981 / Round: 6 / Pick 157
Organizations
As player:
1982-1988	New England Patriots
Stats at DatabaseFootball.com

Background
Ron Wooten (born on June 29, 1959 in Bourne, Massachusetts) serves as president of NovaQuest and executive vice president of corporate development at Quintiles Transnational Corporation, a position he has held since 2003. Wooten joined the firm in July 2000 as a senior vice president of finance to manage the formation of the PharmaBio Development Group (NovaQuest’s predecessor) and to contribute to the execution of merger and acquisition and corporate finance strategies.

Prior to joining Quintiles, Wooten worked for nine years with First Union Securities Corporation (now Wachovia Securities, Inc.) in Charlotte, North Carolina, most recently as a Managing Director of Investment Banking. In this capacity, he advised corporate clients on mergers and acquisition, as well as corporate finance strategies. His capital markets and corporate finance experience includes mergers and acquisitions, public and private equity finance, and fixed income advisory. Earlier in his career at First Union, Wooten helped formulate the product offerings and delivery channels for the company's capital markets business. Mr. Ronald J. Wooten is an Executive Vice President of Corporate Development at Quintiles Transnational Corp. since 2003. Mr. Wooten joined the firm in July 2000 as a Senior Vice President of Finance to manage the formation of the PharmaBio Development Group (NovaQuest’s predecessor) and to contribute to the execution of merger and acquisition and corporate finance strategies.

Wooten received his bachelor's degree in chemistry from the University of North Carolina at Chapel Hill and his master’s of business administration from Boston University. Before beginning his financial career, Wooten was an offensive guard from 1981 to 1990 with the New England Patriots of the National Football League (NFL).

NovaQuest Overview
NovaQuest partners with pharmaceutical and biotechnology companies seeking to overcome challenges that may stifle product development, commercialization and financial goals. As the managed partnership group of Quintiles Transnational, NovaQuest offers accelerated pipeline development, flexible resourcing, new capital streams and access to senior-level expertise.

As president of NovaQuest, Wooten focuses on financing strategies that companies use to develop their products and bring them to market. His approach provides an increased use of strategic outsourcing by large pharmaceutical companies to lower their high fixed-cost infrastructure and increase utilization rates, and by emerging biotech companies to access a “virtual” global development platform rather than build their own. Since NovaQuest’s formation in 2000, Wooten has led the company in creating and managing partnerships with more than $2 billion committed in capital or services to companies of all sizes – from Big Pharmaceutical to start-up biotechs.

Quintiles Transnational Overview
Founded in 1982 by Dennis Gillings, Ph.D., CBE, and headquartered near Research Triangle Park, North Carolina, Quintiles Transnational is the world’s largest pharmaceutical services company with offices in more than 50 countries. Quintiles is the global leader in outsourced development and commercialization solutions, having helped bring to market each of the top 30 best-selling pharmaceutical products and nine of the top 10 biotech products. The company provides a range of support services for pharmaceutical, biotech and medical device companies via three major groups:Quintiles® product development services, Innovex® commercialization and NovaQuest® managed partnering solutions.